Pharmaceutical

Thermo Fisher counters tariffs with $2bn investment into US manufacturing

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.

Apr 26, 2025 - 06:00
Thermo Fisher counters tariffs with $2bn investment into US manufacturing
Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.
Read the original article

Tags:

Previous Article

Challenges in filling for alum drug products: What does a CDMO need to successfu...

Next Article

Human Evolution’s Response to Rising Obesity

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more

STAT+: Pharmalittle: We’re reading about FDA warnings o...

Jan 24, 2024

STAT+: NIH releases data showing more clinical trial sponsors are reporting results, but most miss deadlines

STAT+: NIH releases data showing more clinical trial sp...

Mar 30, 2023

Negative FDA AdCom vote for Intercept’s obeticholic acid in NASH

Negative FDA AdCom vote for Intercept’s obeticholic aci...

Jun 1, 2023